raoult's hydroxychloroquine-covid-19 study did still meet publishing society's expected standard
raoult's hydroxychloroquine-covid-19 study did still meet publishing society's expected standard
another preprint by raoult's group of 80 covid-19 patients who received hydroxychloroquine and the antibiotic azithromycin similarly received criticism for a lack of control group, the inclusion of asymptomatic carriers, and questionable results.", "the april 3, 2020, notice, from the international journal of antimicrobial agents , states that the march 20 article, hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non- randomized clinical trial > does not meet the [international society of antimicrobial chemotherapys] > expected standard, especially relating to the lack of better explanations of > the inclusion criteria and the triage of patients to ensure patient safety."


































)